Skip to main content
Caplight Logo









Neupulse

Neupulse

Private
NottinghamHealthcare & Life Scienceshttps://neupulse.co/en-us

Last Round

Early Funding

Feb 13, 2026

Total Funding Raised

$7.65M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Neupulse is a healthtech company that develops a wearable neuromodulation device designed to reduce tics for individuals with Tourette's Syndrome.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

neuromodulationTourette's syndromemedical wearabletic disorder treatmentnerve stimulationmedian nerve stimulationMNSnon-invasive therapybioelectronic medicineneurotechdigital healthmovement disorder supporthealth IoTwearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neupulse Comparables

Compare Neupulse with similar companies based on industry and business-model similarity.

Neupulse comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neurolief
66%
NeuroSigma
64%
Cala Health
63%

Neupulse Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 13, 2026
SeedJul 31, 2024
SeedMar 18, 2024

Key People

Founding team and executive leadership

Paul Cable

Chief Executive Officer

Executive Team

David Moser

Chief Technology Officer

Executive Team

Neupulse Investors

Notable investors and investment history

Neupulse investors
InvestorRounds
British Business BankSeed, Early Funding
Mercia VenturesEarly Funding, Seed
Eos AdvisoryEarly Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2026

    Grew 31% QoQ, from 16 to 21 employees.

  • Aug 1, 2026

    Grew 25% QoQ, from 16 to 20 employees.

Neupulse Filings

Explore SEC and related filing metadata, where available.

Neupulse filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neupulse's valuation, stock price, and market status.

Is Neupulse a public or private company?

Neupulse is a private company.

What is the current stock price of Neupulse?

Neupulse is a private company with no public stock price. No recent secondary market data is available.

How much is Neupulse worth (valuation)?

Valuation information for Neupulse is not publicly available.

Can I buy Neupulse stock?

Neupulse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neupulse's last funding round?

Neupulse's most recent funding round was Early Funding on February 13, 2026.

Who are the main investors in Neupulse?

Key investors in Neupulse include British Business Bank, Eos Advisory.

Will Neupulse IPO soon?

No public IPO plans have been announced for Neupulse.

How can I track Neupulse secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neupulse's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNottingham
Employee Range14
Year Founded2021
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?